12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Codeine-containing medicines regulatory update

EMA's Co-ordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) endorsed a series of safety recommendations from EMA's Pharmacovigilance Risk Assessment Committee (PRAC) to restrict use of codeine-containing medicines when used for the management of pain in children. Specifically,...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >